Parisa Gazerani
Parisa Gazerani
Verificeret mail på hst.aau.dk
Citeret af
Citeret af
Subcutaneous Botulinum toxin type A reduces capsaicin-induced trigeminal pain and vasomotor reactions in human skin
P Gazerani, NS Pedersen, C Staahl, AM Drewes, L Arendt-Nielsen
PAIN® 141 (1-2), 60-69, 2009
The effects of Botulinum Toxin type A on capsaicin-evoked pain, flare, and secondary hyperalgesia in an experimental human model of trigeminal sensitization
P Gazerani, C Staahl, AM Drewes, L Arendt-Nielsen
Pain 122 (3), 315-325, 2006
Sex-related differences in pain
BE Cairns, P Gazerani
Maturitas 63 (4), 292-296, 2009
MicroRNAs as modulators and biomarkers of inflammatory and neuropathic pain conditions
HH Andersen, M Duroux, P Gazerani
Neurobiology of disease 71, 159-168, 2014
Addressing potential impact of COVID-19 pandemic on physical and mental health of elite athletes
AH Mehrsafar, P Gazerani, AM Zadeh, JCJ Sánchez
Brain, behavior, and immunity 87, 147, 2020
A human experimental capsaicin model for trigeminal sensitization. Gender-specific differences
P Gazerani, OK Andersen, L Arendt-Nielsen
Pain 118 (1-2), 155-163, 2005
Pressure pain thresholds assessed over temporalis, masseter, and frontalis muscles in healthy individuals, patients with tension-type headache, and those with migraine—A …
S Andersen, MW Petersen, AS Svendsen, P Gazerani
Pain 156 (8), 1409-1423, 2015
Migraine and diet
P Gazerani
Nutrients 12 (6), 1658, 2020
Effects of subcutaneous administration of glutamate on pain, sensitization and vasomotor responses in healthy men and women
P Gazerani, K Wang, BE Cairns, P Svensson, L Arendt-Nielsen
Pain 124 (3), 338-348, 2006
Probiotics for Parkinson’s disease
P Gazerani
International journal of molecular sciences 20 (17), 4121, 2019
Determination of metformin in human plasma by high-performance liquid chromatography
H Amini, A Ahmadiani, P Gazerani
Journal of Chromatography B 824 (1-2), 319-322, 2005
Botulinum neurotoxin type A (BoNTA) decreases the mechanical sensitivity of nociceptors and inhibits neurogenic vasodilation in a craniofacial muscle targeted for migraine …
P Gazerani, S Au, X Dong, U Kumar, L Arendt-Nielsen, BE Cairns
PAIN® 151 (3), 606-616, 2010
Botulinum toxin type a as a therapeutic agent against headache and related disorders
S Luvisetto, P Gazerani, C Cianchetti, F Pavone
Toxins 7 (9), 3818-3844, 2015
The effects of mindfulness training on competition-induced anxiety and salivary stress markers in elite Wushu athletes: A pilot study
AH Mehrsafar, J Strahler, P Gazerani, M Khabiri, JCJ Sánchez, ...
Physiology & behavior 210, 112655, 2019
Serum microRNA signatures in migraineurs during attacks and in pain-free periods
HH Andersen, M Duroux, P Gazerani
Molecular neurobiology 53, 1494-1500, 2016
Botulinum toxin type A reduces histamine‐induced itch and vasomotor responses in human skin
P Gazerani, NS Pedersen, AM Drewes, L Arendt‐Nielsen
British Journal of Dermatology 161 (4), 737-745, 2009
A correlation between migraine, histamine and immunoglobulin E
P Gazerani, Z Pourpak, A Ahmadiani, A Hemmati, A Kazemnejad
Scandinavian journal of immunology 57 (3), 286-290, 2003
Lactobacillus rhamnosus PB01 (DSM 14870) supplementation affects markers of sperm kinematic parameters in a diet-induced obesity mice model
F Dardmeh, H Alipour, P Gazerani, G van der Horst, E Brandsborg, ...
PLoS One 12 (10), e0185964, 2017
Effect of local controlled heat on transdermal delivery of nicotine
KK Petersen, ML Rousing, C Jensen, L Arendt-Nielsen, P Gazerani
International journal of physiology, pathophysiology and pharmacology 3 (3), 236, 2011
The impact of ethnic differences in response to capsaicin-induced trigeminal sensitization
P Gazerani, L Arendt-Nielsen
Pain 117 (1-2), 223-229, 2005
Systemet kan ikke foretage handlingen nu. Prøv igen senere.
Artikler 1–20